A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

BERLIN, Nov 23 (Reuters) - German pharma company Bayer (BAYGn.DE), opens new tab reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

Occultus, the Latin root for “occult,” points to the hidden and the obscured—an apt source for a word steeped in mystery. For centuries after the term’s wider adoption, it has continued to suggest the ...

RALEIGH, N.C. (WKRC) — A hospital patient allegedly removed an IV from his arm and used his "HIV positive blood" as a weapon by spraying it into the eyes of medical personnel. According to an arrest ...

He plans to open it up to the public for tours and overnight stays. By Lexi Carson Associate Editor “I have officially purchased Ed and Lorraine Warren’s home and Occult Museum, including being the ...

San Antonio Spurs star Victor Wembanyama has been officially cleared to return to play basketball, he told Maxime Aubin of L'Équipe. Wembanyama missed most of the second half of the 2025-26 season ...

Dr Ashwill Ramon Phillips does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

Joaquim M.B. Pinheiro, MD, MPH, David A. Clark, MD, Kathleen G. Benjamin, RNC, MSN, NNP Echevarria Ybarguengoitia, using bililabstix to prospectively evaluate occult hematochezia in 300 premature ...

A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...

Clinical trials to explore the use of universal artificial blood are underway in Japan after initial volunteer doses began in March. The research, led by Professor Hiromi Sakai's laboratory, plans to ...